PLAT and Stroke: miR-155 plays a key role in promoting the pathogenesis of IS, including oxidative stress, apoptosis, neuroinflammation, and microglia/astrocyte polarization, making miR-155 inhibitors attractive therapeutics to manage the acute phase of stroke that could be combined with current standard IS therapies (e.g., tPA and thrombectomy).